Select Publications
Journal articles
, 2018, 'Evaluation of the effect of baseline MRI sacroiliitis and c reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: A post hoc analysis of the EMBARK study', Annals of the Rheumatic Diseases, 77, pp. 1090 - 1093, http://dx.doi.org/10.1136/annrheumdis-2017-211313
, 2018, 'Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors', Clinical Rheumatology, 37, pp. 1617 - 1623, http://dx.doi.org/10.1007/s10067-018-4105-3
, 2018, '226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population', Rheumatology, 57, http://dx.doi.org/10.1093/rheumatology/key075.450
, 2018, 'Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis', Clinical Rheumatology, 37, pp. 383 - 388, http://dx.doi.org/10.1007/s10067-017-3895-z
, 2018, 'AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis', International Journal of Rheumatology, 2018, pp. 8721753, http://dx.doi.org/10.1155/2018/8721753
, 2018, 'Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: A multi-centre Australian study', International Journal of Rheumatic Diseases, 21, pp. 510 - 516, http://dx.doi.org/10.1111/1756-185X.13127
, 2018, 'Optimal control of diffuser shapes for non-uniform flow', JOURNAL OF ENGINEERING MATHEMATICS, 113, pp. 65 - 92, http://dx.doi.org/10.1007/s10665-018-9974-6
, 2018, 'Turbulent shear layers in confining channels', JOURNAL OF TURBULENCE, 19, pp. 431 - 445, http://dx.doi.org/10.1080/14685248.2018.1459630
, 2017, 'Vertebroplasty for acute painful osteoporotic fracture', Medical Journal of Australia, 207, pp. 279 - 281.e1, http://dx.doi.org/10.5694/mja16.01423
, 2017, 'Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect', Evidence Based Medicine, 22, pp. 116 - 117, http://dx.doi.org/10.1136/ebmed-2017-110737
, 2017, 'Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study', International Journal of Rheumatic Diseases, 20, pp. 460 - 468, http://dx.doi.org/10.1111/1756-185X.13036
, 2017, 'Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)', Annals of the Rheumatic Diseases, 76, pp. 694 - 700, http://dx.doi.org/10.1136/annrheumdis-2016-209821
, 2017, 'Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand', Journal of Medical Imaging and Radiation Oncology, 61, pp. 58 - 69, http://dx.doi.org/10.1111/1754-9485.12573
, 2017, 'The CEDAR Study: A longitudinal study of the clinical effects of conventional DMARDs and biologic DMARDs in Australian rheumatology practice', International Journal of Rheumatology, 2017, pp. 1201450, http://dx.doi.org/10.1155/2017/1201450
, 2017, 'A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER TRIAL OF HUMIRA (ADALIMUMAB) FOR EROSIVE HAND OSTEOARTHRITIS: THE HUMOR TRIAL', OSTEOARTHRITIS AND CARTILAGE, 25, pp. S9 - S9, http://dx.doi.org/10.1016/j.joca.2017.02.032
, 2016, 'Apremilast monotherapy as the first systemic treatment in DMARD-naive patients with active psoriatic arthritis: 3-year treatment results', Revue Du Rhumatisme Edition Francaise, 83, pp. A249, http://dx.doi.org/10.1016/S1169-8330(16)30589-0
, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 Phase III, randomized, controlled trials', Revue Du Rhumatisme Edition Francaise, 83, pp. A248 - A249, http://dx.doi.org/10.1016/S1169-8330(16)30588-9
, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)', Annals of the Rheumatic Diseases, 75, pp. 1065 - 1073, http://dx.doi.org/10.1136/annrheumdis-2015-207963
, 2016, '194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials', Rheumatology, http://dx.doi.org/10.1093/rheumatology/kew145.005
, 2016, 'Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy', Journal of Rheumatology, 43, pp. 75 - 80, http://dx.doi.org/10.3899/jrheum.150347
, 2016, 'A RETROSPECTIVE NON-INTERVENTIONAL MULTI-CENTRE STUDY EVALUATING TREATMENT REGIMENS USED IN PSORIATIC ARTHRITIS PATIENTS IN AUSTRALIA-THE PSA REAL STUDY', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 348 - 348, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2099
, 2016, 'A RETROSPECTIVE NON-INTERVENTIONAL STUDY ON THE USE OF BIOLOGICS IN THE TREATMENT OF AUSTRALIAN PATIENTS WITH RHEUMATOID ARTHRITIS-THE REAL STUDY', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 1019 - 1020, http://dx.doi.org/10.1136/annrheumdis-2016-eular.4470
, 2016, 'AC-CUTE: AN OPEN-LABEL STUDY TO EVALUATE NON-PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 1029 - 1030, http://dx.doi.org/10.1136/annrheumdis-2016-eular.3780
, 2016, 'APREMILAST MONOTHERAPY AS THE FIRST SYSTEMIC TREATMENT IN DMARD-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 3-YEAR TREATMENT RESULTS', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 342 - 342, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2405
, 2016, 'APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENT IN FATIGUE IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 346 - 346, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1487
, 2016, 'RELIABILITY OF AN OMERACT RHEUMATOID ARTHRITIS TENOSYNOVITIS SCORING SYSTEM FOR WRIST AND HAND', ANNALS OF THE RHEUMATIC DISEASES, 75, pp. 627 - 628, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1445
, 2016, 'Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial', Lancet, 388, pp. 1408 - 1408, http://dx.doi.org/10.1016/S0140-6736(16)31341-1
, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114 - 114, http://dx.doi.org/10.1504/ijac.2016.082027
, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114 - 114, http://dx.doi.org/10.1504/ijac.2016.10002935
, 2015, 'The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)', Journal of Rheumatology, 42, pp. 2486 - 2491, http://dx.doi.org/10.3899/jrheum.140983
, 2015, 'The OMERACT MRI in arthritis working group - Update on status and future research priorities', Journal of Rheumatology, 42, pp. 2470 - 2472, http://dx.doi.org/10.3899/jrheum.141248
, 2015, 'Validation of the OMERACT magnetic resonance imaging joint space narrowing score for the wrist in a multireader longitudinal trial', Journal of Rheumatology, 42, pp. 2480 - 2485, http://dx.doi.org/10.3899/jrheum.141009
, 2015, 'Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial', Journal of Rheumatology, 42, pp. 2473 - 2479, http://dx.doi.org/10.3899/jrheum.141010
, 2015, 'Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial', LANCET, 386, pp. 1137 - 1146, http://dx.doi.org/10.1016/S0140-6736(15)61134-5
, 2015, 'Patients with rheumatoid arthritis in the Australian OPAL cohort show significant improvement in disease activity over 5 years: A multicenter observational study', Journal of Rheumatology, 42, pp. 1603 - 1609, http://dx.doi.org/10.3899/jrheum.141575
, 2015, 'Utility of in-office extremity magnetic resonance imaging in rheumatology', Indian Journal of Rheumatology, 10, pp. 140 - 146, http://dx.doi.org/10.1016/j.injr.2015.06.002
, 2015, 'A NOVEL, FULLY 3-DIMENSIONAL DYNAMIC CONTRAST MRI METHOD IN THE HAND REVEALS DETAILS OF SYNOVIAL INFLAMMATION AND PROVIDES A SENSITIVE MEASURE OF CHANGE', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 879 - 879, http://dx.doi.org/10.1136/annrheumdis-2015-eular.6400
, 2015, 'CAN WE STOP USING CONTRAST IN RA MRI CLINICAL TRIALS? QUANTITATIVE MRI DEMONSTRATES SIMILAR RESPONSIVENESS FOR CONTRAST AND CONTRAST-FREE SYNOVITIS ASSESSMENT', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 873 - 873, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4884
, 2015, 'Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): Study protocol for a randomized controlled trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0671-8
, 2015, 'BASELINE MRI/CRP AS PREDICTORS OF RESPONSE TO ETANERCEPT IN THE MANAGEMENT OF PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 752 - 752, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2254
, 2015, 'DISPENSING OF BIOLOGICS PRESCRIBED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE AUSTRALIAN POPULATION', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 246 - 247, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4326
, 2015, 'LONG-TERM (104-WEEK) EFFICACY AND SAFETY OF APREMILAST MONOTHERAPY IN DMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: A PHASE 3, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 4)', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 863 - 864, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2896
, 2014, 'How well do patients understand written instructions?: health literacy assessment in rural and urban rheumatology outpatients', Medicine, 93, pp. e129, http://dx.doi.org/10.1097/MD.0000000000000129
, 2014, 'RHEUMATOID ARTHRITIS PATIENTS IN AUSTRALIAN DATABASE SHOW SIGNIFICANT IMPROVEMENT IN DISEASE ACTIVITY OVER 5 YEARS', ANNALS OF THE RHEUMATIC DISEASES, 73, pp. 883 - 883, http://dx.doi.org/10.1136/annrheumdis-2014-eular.4834
, 2014, 'No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: Results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial', Rheumatology United Kingdom, 53, pp. 746 - 756, http://dx.doi.org/10.1093/rheumatology/ket426
, 2014, 'Ultrasound versus high-field magnetic resonance imaging in rheumatoid arthritis', Clinical and Experimental Rheumatology, 32, pp. 99 - 105
, 2014, 'Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity', Arthritis Care and Research, 66, pp. 190 - 196, http://dx.doi.org/10.1002/acr.22108
, 2014, 'Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: Results from a followup MRI Study of 254 patients in clinical remission or low disease activity', Journal of Rheumatology, 41, pp. 398 - 406, http://dx.doi.org/10.3899/jrheum.131088
, 2014, 'The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: Intrareader and interreader reliability and agreement with computed tomography and conventional radiography', Journal of Rheumatology, 41, pp. 392 - 397, http://dx.doi.org/10.3899/jrheum.131087
, 2014, 'Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)', International Journal of Rheumatic Diseases, 17, pp. 548 - 556, http://dx.doi.org/10.1111/1756-185X.12358